Microba Life Sciences Limited
MAP.AX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$36.57M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $36.57 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.03 |
| Beta | 2.1 |
| Outstanding Shares | 616,069,133 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -1.48 |
|---|---|
| PEG | -14.06 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 30, 2026
EPS Estimate
$-0.01
Consensus analyst estimateRevenue Estimate
$7.50 M
Consensus analyst estimateNext Earnings Call
Expected Date
March 3, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$8.64 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Microba Life Sciences Limited
80 employees
CEO: Luke Reid
Microba Life Sciences Limited, established in Brisbane, Australia, in 2017, specializes in providing sophisticated microbiome testing and analytical services. These offerings reach clinicians, individual consumers, and research customers...